ROLE OF MATRIX METALLOPROTEINASES AND PLASMINOGEN ACTIVATORS IN CANCER INVASION AND METASTASIS: THERAPEUTIC STRATEGIES

This publication has 157 references indexed in Scilit:

• Functional activation of integrin ?v?3 in tumor cells expressing membrane-type 1 matrix metalloproteinase
  International Journal of Cancer, 2000
• Role and Localization of Urokinase Receptor in the Formation of New Microvascular Structures in Fibrin Matrices
  The American Journal of Pathology, 1999
• Cloning and Characterization of Human MMP-23, a New Matrix Metalloproteinase Predominantly Expressed in Reproductive Tissues and Lacking Conserved Domains in Other Family Members
  Journal of Biological Chemistry, 1999
• High Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV
  Journal of Biological Chemistry, 1998
• Activation of β1 Integrin Signaling Stimulates Tyrosine Phosphorylation of p190 and Membrane-protrusive Activities at Invadopodia
  Journal of Biological Chemistry, 1998
• Urokinase Antisense Oligodeoxynucleotides as a Novel Therapeutic Agent for Malignant Glioma:In Vitroandin VivoStudies of Uptake, Effects and Toxicity
  Biochemical and Biophysical Research Communications, 1996
• Plasma assay of gelatinase B:Tissue inhibitor of metalloproteinase complexes in cancer
  Cancer, 1995
• Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis model
  International Journal of Cancer, 1994
• Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: Not an invariant correlation with metastasis
  International Journal of Cancer, 1992
• Tumors: Wounds That Do Not Heal
  New England Journal of Medicine, 1986